In a nutshell The authors assessed the safety and efficacy of ramucirumab (Cyramza) for patients with metastatic colorectal cancer (cancer that has spread from the colon or rectum to distant sites) that has progressed despite treatment. Some background Ramucirumab has recently been approved for the treatment of metastatic colorectal cancer....
Read MoreCurrent disease status-First occurrence of the cancer Posts on Medivizor
Poor performance status: should chemotherapy still be given?
In a nutshell The authors examined whether chemotherapy can benefit metastatic colorectal cancer patients (patients whose cancer has spread from the colon or rectum to distant sites) with high ECOG scores. Some background The ECOG scoring system measures how much the cancer is impacting a patient’s daily living abilities (performance...
Read MoreChemotherapy before surgery; is there a different in outcome between different types of breast cancer?
In a nutshell The authors aimed to evaluate if the outcomes of surgery following chemotherapy are different based on the focality of breast cancer tumors. Some background Breast cancer can be characterised as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found...
Read More‘Stops and starts’ – an acceptable method of administering hormone therapy in prostate cancer?
In a nutshell The authors aimed to determine the effect of degarelix in treating prostate cancer. Some background Hormone therapy is a prostate cancer treatment that targets the male sex hormones active in prostate cancer, such as testosterone. Degarelix (Firmagon) is a drug used in hormone therapy that reduces the levels of testosterone to...
Read MoreLung invasion: what are the outcomes of colorectal cancer patients who have undergone lung surgery?
In a nutshell This study examined cancer relapse rates and treatment options for patients with colorectal lung metastases (colorectal cancer that has spread to the lungs) after curative lung surgery. Some background Roughly 20% of patients with colorectal cancer will have cancer in a distant organ by the time they are diagnosed. The cancer will...
Read MoreIs age related to treatment side-effects experienced in prostate cancer patients?
In a nutshell The authors aimed to determine whether age had an effect on patient quality of life after localized prostate cancer treatment. Some background Localized prostate cancer is cancer that is confined within the prostate gland. Treatment for localized prostate cancer can cause undesirable effects in patients, affecting their quality...
Read MoreWho says age matters? Bevacizumab (Avastin) is safe and effective for treating colorectal cancer in patients old and young
In a nutshell This study examined the safety and efficacy of bevacizumab (Avastin) for treating elderly patients with metastatic colorectal cancer (cancer that has spread from the colon or rectum to distant sites). Some background Bevacizumab is an anti-cancer drug that blocks the formation of new blood vessels needed for the cancer to grow and...
Read MoreEffect of sentinel lymph node biopsy on head and neck skin cancer
In a nutshell The aim of this research was to analyze the effect of a diagnostic procedure known as sentinel lymph node biopsy on survival in patients with head and neck skin cancer. Some background Melanoma is a type of cancer that starts in color-producing cells of the skin. It can grow deep into the inner layers of skin and spread into...
Read MoreIs capecitabine better with lapatinib or trastuzumab for HER2 positive metastatic breast cancer?
In a nutshell This paper studied the effect of lapatinib (Tyverb) plus capecitabine (Xeloda) versus trastuzumab (Herceptin) plus capecitabine in patients with human epidermal growth factor receptor 2 (HER2) positive breast cancer that has spread to other parts of the body. Some background Trastuzumab is used to treat HER2 positive breast...
Read MoreComparing urinary incontinence and erectile dysfunction as side effects after robotic vs. open prostate removal
In a nutshell This study aimed to evaluate the complications associated with robotic-assisted prostate removal (minimally invasive) compared to an open surgical procedure (more invasive). Some background Open surgical removal of the prostate has previously been the traditional surgical approach for prostate cancer treatment. Robot-assisted...
Read MoreDacomitinib after erlotinib failure: modest effects in non-small cell lung cancer
In a nutshell This study aimed to assess use of dacomitinib in patients with advanced non-small cell lung cancer (NSCLC) who had previously failed to respond to chemotherapy and erlotinib (Tarceva). Some background NSCLC is the most common type of lung cancer. Erlotinib and gefitinib (Iressa) are used to treat NSCLC. They...
Read MoreCalling on patients with colorectal cancer that has spread to the liver to test a drug treatment option
In a nutshell This study is being carried out in New York and New Jersey. It will examine whether adding panitumumab (Vectibix) to chemotherapy reduces the risk of the cancer returning in colorectal cancer patients with liver metastases (cancer that has spread to the liver). The authors will also record any adverse events experienced and patient...
Read More